Get a fresh start.
Add this topic to your myFT Digest for news straight to your inbox
Rapid medical innovation is prompting drug company mergers and making treatment costly
Virgin looks to expand in the US, Theresa May is expected to ask MPs for more time t…
The immunotherapy used with Pfizer’s Inlyta halves the risk of dying from condition
The biggest movers include Goldman Sachs, Merck and AMD
The pharma company reported a third-quarter profit compared to last year’s loss
Patients taking US group’s lung cancer drug lived longer than those on chemotherapy
Discordant notes expected at this year’s Asco, a kind of rock festival for pharma
Company says test results show ‘unambiguous’ improvement in survival rates
Merck slides and Incyte loses $4bn market value as ‘combination’ cancer study flops
Clinical setbacks in cancer research are likely to be punished
Japanese group’s tie-up with US pharma on cancer drug will boost its research on Alzheimer’s
Companies analysis from our sister publication
GSK and MSD among 25 companies included in government’s £1bn ‘sector deal’
Nearly 1,000 new high-skilled jobs planned for research hubs in London and Manchester
Shares gain on back of positive data presented at Madrid oncology conference
Biotech hopes to turn our bodies into ‘drug factories’ able to create own cures
The results have not always matched the president’s rhetoric on corporate investment
Union leaders and steel industry representative resign over Charlottesville
President’s denunciation of white supremacists fails to stem defections
